Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anatomy of the Eyeball01:20

Anatomy of the Eyeball

7.8K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
7.8K
The Retina01:32

The Retina

71.4K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
71.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification and enrichment of human retinal organoid-derived red/green cone-competent precursors with enhanced axon dynamics.

Stem cell research & therapy·2026
Same author

CTCF regulates wild-type and recombinant AAV gene expression by shaping viral chromatin.

bioRxiv : the preprint server for biology·2026
Same author

Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis.

Signal transduction and targeted therapy·2026
Same author

A porcine commotio retinae model for preclinical evaluation of posttraumatic photoreceptor degeneration.

JCI insight·2026
Same author

Monitoring biological effects of somatic cell genome editing.

Nature reviews. Genetics·2026
Same author

Metabolic stress and early cell death in photoreceptor precursor cells following retinal transplantation.

Stem cell research & therapy·2025
Same journal

The Role of Nrf2 in SIRT1-Mediated RGC Neuroprotection in Traumatic Optic Neuropathy.

Translational vision science & technology·2026
Same journal

Explicit Inclusion of Diabetes Mellitus Without Retinopathy Within Diabetic Retinopathy Prediction.

Translational vision science & technology·2026
Same journal

Preclinical Safety and Feasibility Study of Line-Field Confocal Optical Coherence Tomography for Ophthalmology Applications.

Translational vision science & technology·2026
Same journal

Pathogenicity Analysis of Two Novel CRB1 Mutations in Three Chinese Inherited Retinal Dystrophy Families and a Literature Review.

Translational vision science & technology·2026
Same journal

Gas-Lesion Contact and Postural Compliance After Vitrectomy With Tamponade: A Continuous Monitoring and 3D Quantitative Analysis.

Translational vision science & technology·2026
Same journal

Automated Deep Learning Quantification of Avascular Area and Intravitreal Neovascularization in Retinal Flatmounts of Rodent Oxygen-Induced Retinopathy Models.

Translational vision science & technology·2026
See all related articles

Related Experiment Video

Updated: Oct 14, 2025

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
11:03

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

Published on: January 22, 2018

10.1K

Outer Retinal Cell Replacement: Putting the Pieces Together.

Allison L Ludwig1,2,3, David M Gamm1,2,4

  • 1Waisman Center, University of Wisconsin-Madison, Madison, WI, USA.

Translational Vision Science & Technology
|November 1, 2021
PubMed
Summary
This summary is machine-generated.

Human pluripotent stem cells offer hope for treating incurable blindness caused by retinal degenerative diseases. This review explores challenges and strategies for cell replacement therapies to restore vision.

More Related Videos

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

9.4K
Subretinal Transplantation of MACS Purified Photoreceptor Precursor Cells into the Adult Mouse Retina
08:28

Subretinal Transplantation of MACS Purified Photoreceptor Precursor Cells into the Adult Mouse Retina

Published on: February 22, 2014

10.9K

Related Experiment Videos

Last Updated: Oct 14, 2025

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
11:03

Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy

Published on: January 22, 2018

10.1K
Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells
07:07

Efficient Derivation of Retinal Pigment Epithelium Cells from Stem Cells

Published on: March 8, 2015

9.4K
Subretinal Transplantation of MACS Purified Photoreceptor Precursor Cells into the Adult Mouse Retina
08:28

Subretinal Transplantation of MACS Purified Photoreceptor Precursor Cells into the Adult Mouse Retina

Published on: February 22, 2014

10.9K

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Retinal degenerative diseases (RDDs) cause incurable blindness by damaging photoreceptors (PRs) and retinal pigmented epithelium (RPE).
  • Current treatments lack endogenous repair mechanisms, necessitating cell replacement therapies for vision restoration.
  • Human pluripotent stem cells (hPSCs) provide a renewable source for developing these cell therapies.

Purpose of the Study:

  • To review the history and current status of neuroretinal and PR cell transplantation for RDDs.
  • To identify remaining challenges in hPSC-based outer retinal cell replacement therapies.
  • To propose a stepwise approach for addressing key issues in PR replacement.

Main Methods:

  • Review of existing literature on neuroretinal and PR cell transplantation.
  • Analysis of progress and challenges in hPSC-derived RPE and PR cell therapies.
  • Discussion of safety and efficacy considerations, including biomaterial transfer.

Main Results:

  • hPSC-RPE replacement therapies are clinically advanced with ongoing trials.
  • hPSC-PR replacement therapies are in early stages, with a first-in-human trial initiated.
  • Significant questions remain regarding survival, integration, and function of transplanted hPSC-PRs.

Conclusions:

  • Cell replacement therapies, particularly using hPSCs, hold promise for treating RDDs.
  • Further research is crucial to address challenges in hPSC-PR transplantation for safety and efficacy.
  • A systematic approach is needed to overcome hurdles in outer retinal cell replacement.